Gold Up Over Cautious U.S. Stimulus Hopes, Vaccine Hiccups By Investing.com

© Reuters.

By Gina Lee

Investing.com – Gold was up on Friday morning in Asia, as investors were cautiously optimistic over the latest U.S. stimulus measures and as Pfizer Inc (NYSE:) cut the number of COVID-19 vaccine doses that it will roll out.

were up 0.26% at $1,845.80 by 11:48 PM ET (3:48 AM GMT) as investors slowly turned to the safe-haven yellow metal. Holdings of the SPDR Gold Trust (P:) fell 0.1% to 1,189.82 tons on Thursday from 1,191.28 tons on Wednesday.

Pfizer said on Thursday that it would produce only 50 million doses of BNT162b2, its COVID-19 vaccine co-developed with BioNTech, after reports of supply chain issues. The number of doses is down from an earlier target of 100 million doses.

A bipartisan, $908 billion proposed package was slowly gaining momentum in the U.S. Congress on Thursday. Democrats and Republicans have until Dec. 11 to reach a consensus on the package’s price tag and avert a government shutdown.

The country also continues to fight a virulent second wave of COVID-19 cases. U.S. hospitalizations topped 100,000, and California’s governor Gavin Newson warned stay-at-home orders could be imposed in every region of the state, the San Francisco Bay Area excepted, later in the week.

Data released on Thursday also highlighted COVID-19’s economic impact, with 712,000 filed during the past week. The number of claims was down from the forecasted 775,000 claims and the previous week’s 787,000 claims but remaining high. Further labor market data, including and , are due later in the day.

Meanwhile, the U.S. Federal Reserve and the European Central Bank will meet for their respective policy decisions during the following week.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function()
{n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,’script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘751110881643258’);
fbq(‘track’, ‘PageView’);

by : Investing.com

Source link

Capital Media

Read Previous

most people want to get back to the office, but not for the full week

Read Next

Stocks enjoy record inflows as gold loses lustre on vaccine trade: BofA By Reuters